FEBS Letters
Volume 583, Issue 18 , Pages 3021-3026, 17 September 2009

Genetic and pharmacological evidence of intraneuronal Aβ accumulation in APP transgenic mice

Edited by Barry Halliwell

  • Ola Philipson
  • ,
  • Lars Lannfelt
  • ,
  • Lars N.G. Nilsson

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Public Health & Caring Sciences/Molecular Geriatrics, Rudbeck Laboratory, Dag Hammarskjölds Väg 20, SE-751 85 Uppsala, Sweden. Fax: +4618 471 48 08.

Department of Public Health and Caring Sciences, Uppsala University, SE-751 85 Uppsala, Sweden

Received 7 July 2009; received in revised form 3 August 2009; accepted 6 August 2009. published online 14 August 2009.

Abstract 

Intraneuronal punctate immunostaining in Alzheimer’s disease brain and amyloid-β precursor protein (APP) transgenic mice has been suggested to represent Aβ, but this is somewhat controversial. Here we show that both biochemical Aβ levels and intraneuronal immunostaining are reduced in APP transgenic mice when γ-secretase is inhibited. Moreover, BACE-1 deficient APP transgenic mice show neither Aβ production nor intraneuronal immunostaining. Our findings suggest that the punctate immunostaining with APP antibodies is due to Aβ that has accumulated inside neurons. Similar type of intraneuronal Aβ accumulation, which precedes senile plaque formation, may link Aβ to tauopathy and neurodegeneration in Alzheimer’s disease pathogenesis.

Keywords: Amyloid precursor protein secretases, Amyloid beta protein, Bace1 protein, mouse, Immunohistochemistry, Intracellular space, Mice, transgenic

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(09)00620-6

doi:10.1016/j.febslet.2009.08.009

FEBS Letters
Volume 583, Issue 18 , Pages 3021-3026, 17 September 2009